Skip to main content
Main Corporate Nav
About Us
Overview
Leadership
Board of Directors
Partnering
Our History
Pipeline
Overview
AL Amyloidosis & Birtamimab
Parkinson's Disease & Prasinezumab
ATTR Amyloidosis & PRX004
Alzheimer's Disease
Pioneering Neuroscience
Publications
Clinical Trials
Overview
Birtamimab Phase 3 Study
Prasinezumab Phase 2 Study
PRX004 Phase 1 Study
Expanded Acces Policy
Investors
Overview
Press Releases
Events & Presentations
Financials & Filings
Corporate Governance
Stock information
Analyst Coverage
Careers
Overview
Our Values
Compensation & Benefits
Opportunities
Public House
Contact Us
Committee Composition
Overview
Press Releases
Events & Presentations
Financials & Filings
SEC Filings
Quarterly Results
Key Ratios
Irish Statutory Financial Statements
Corporate Governance
Committee Composition
Stock Information
Analyst Coverage